CellSeed Company
CellSeed develops regenerative medicine products primarily in Japan and Europe.
Technology:
Regenerative Medicine
Industry:
Alternative Medicine, Health Care, Market Research
Headquarters:
Japan
Founded Date:
2001-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
16
Total Funding:
3167328000
Estimated Revenue:
Less than $1M
Last Funding Date:
41702
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership